Virtus Advisers LLC Grows Stock Position in Cardinal Health, Inc. $CAH

Virtus Advisers LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 69.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,006 shares of the company’s stock after acquiring an additional 824 shares during the period. Virtus Advisers LLC’s holdings in Cardinal Health were worth $337,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in CAH. Norges Bank acquired a new stake in Cardinal Health during the 2nd quarter worth $584,420,000. Wellington Management Group LLP boosted its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after acquiring an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI grew its stake in Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter. Finally, Acadian Asset Management LLC raised its holdings in Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after acquiring an additional 807,063 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.4%

Shares of NYSE:CAH opened at $212.26 on Monday. The company has a market capitalization of $50.43 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a 12-month low of $114.60 and a 12-month high of $214.93. The business has a 50-day moving average price of $177.57 and a 200 day moving average price of $163.50.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same quarter last year, the firm posted $1.88 earnings per share. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of analyst reports. Robert W. Baird set a $232.00 price target on Cardinal Health in a research report on Friday, October 31st. Leerink Partners boosted their price objective on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. Evercore ISI raised their target price on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $206.57.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.